Blood pressure trajectories during early pregnancy can stratify future hypertension risk
NIH-supported study reveals new risk group for future high blood pressure, heart disease.
FGFR2 identified as key driver in KRAS-mutated pancreatic cancer progression
Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had higher-than-normal expression of the FGFR2 protein, and FGFR2 inactivation delayed KRAS-mutated PDAC development in mice.
US FDA approves first treatment for hyperphagia in Prader-Willi syndrome
The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS).
New drug shows neuroprotective and anti-inflammatory effects in murine models of Alzheimer’s
Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease.
Fat cells trigger liver stress through secreted lipids
The endoplasmic reticulum (ER) is the portion of the cell responsible for manufacturing and folding proteins.
Breakthrough research reveals gut-eye connection in vision loss
Inherited retinal degeneration (IRD) encompasses various disorders characterized by progressive loss of retinal photoreceptor cells, ultimately leading to vision loss and blindness.
AI predicts bacterial resistance to antibiotics with high accuracy
An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant.
Understanding the phases and treatment options for Peyronie’s disease
The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was published on November 12, 2024 in UroPrecision.
New insights into how disruption of calcium transport leads to autism and intellectual disability
A new study by McGill University researchers yields insights into how the disruption of calcium transport in the brain is linked to autism and intellectual disability.
New class of antibiotic selectively targets gonorrhea bacterium
Researchers from the universities in Konstanz and Vienna discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhea.